Aurobindo Pharma

Company Legal / IP

AbbVie Sues to Protect Rinvoq from Generic Competition in the US Market

Fineline Cube Nov 27, 2023

AbbVie (NYSE: ABBV) has initiated legal action in the US to safeguard its blockbuster drug...

Company

Aurobindo Pharma’s China Plant Secures EU GMP Approval, Eyes Revenue Generation

Fineline Cube Nov 20, 2023

India-based Aurobindo Pharma reportedly received EU GMP approval for its China-based manufacturing plant last week,...

Policy / Regulatory

U.S. Tariffs on Pharmaceuticals and Their Impact on China’s Medical Industry

Company Drug

Sichuan Biokin Launches Phase III Trial for BL-B01D1 in Urothelial Carcinoma

Company Drug

AbbVie’s Rinvoq Approved in EU for Giant Cell Arteritis

Company Drug

Bristol-Myers Squibb’s Opdivo/Yervoy Combo Approved for MSI-H Colorectal Cancer